Article may be outdated

This article is 11 days old. Some details may have changed since publication.

Headlinne
Sign inGet Headlinne
Psychiatric Times·4 min read·hard

Sequencing and Positioning Antipsychotic Formulations in Schizophrenia Care

G
Gustavo Alva, MD, DFAPA, Hara Oyedeji, DNP, PMHNP-BC, Mark Jankelow, MSN, PMHNP-BC, Christoph U. Correll, MD, John M. Kane, MD
Sequencing and Positioning Antipsychotic Formulations in Schizophrenia Care
✦AI Summary

Dr. Hara Oyedeji discusses the strategic sequencing of antipsychotic medications for schizophrenia, emphasizing the importance of early intervention and patient-centered formulation selection. She highlights the benefits of long-acting injectables for maintaining long-term stability.

Why it mattersUnlock →

In this episode, "Sequencing and Positioning Antipsychotic Formulations in Schizophrenia Care," the expert psychiatric mental health nurse practitioner Dr. Hara Oyedeji explores the nuanced decision-making process behind sequencing and positioning oral, long-acting injectable, and transdermal antipsychotic formulations across the schizophrenia treatment journey.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
health
Political bias analysisUnlock →
Read originalGet full access
✦

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in

Sequencing and Positioning Antipsychotic Formulations in Schizophrenia Care — Headlinne — headlinne